GSK GSK plc
GSK plc (GSK) is expected to report earnings on October 27, 2026, before the market open. The consensus earnings estimate is $1.46 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -8.7% since its last earnings release on July 28, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About GSK plc
GlaxoSmithKline PLC incorporated in United Kingdom. The Company creates, discoveres, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products.
Sector
Healthcare
Industry
Drug Manufacturers / Major